Themes and Topics
The SfN Program Committee assigns abstracts to topical poster or nanosymposium sessions according to their theme and topic, as selected by abstract submitters.
A searchable list of Neuroscience 2024 is available via PDF. After opening the document, please use key command CTRL + F and enter your search term. The results will be highlighted in the right scroll bar.
- Theme A: Development
- Theme B: Neural Excitability, Synapses, and Glia
- Theme C: Neurodegenerative Disorders and Injury
- Theme D: Sensory Systems
- Theme E: Motor Systems
- Theme F: Integrative Physiology and Behavior
- Theme G: Motivation and Emotion
- Theme H: Cognition
- Theme I: Techniques
- Theme J: History, Education, and Society
Theme A: Development
- A.01. Neurogenesis and Gliogenesis
A.01.a. Proliferation, migration, and cell death
A.01.b. Mechanisms of cell fate
A.01.c. Neuronal differentiation
A.01.d. Glial development - A.02. Postnatal Neurogenesis
A.02.a. Postnatal neurogenesis – Temporal and spatial patterns
A.02 b. Postnatal neurogenesis – Molecular mechanisms and regulation - A.03. Stem Cells and Reprogramming
A.03.a. Pluripotent stem cells – Disease models
A.03.b. Pluripotent stem cells – Differentiation and reprogramming
A.03.c. Neural stem cells - A.04. Transplantation and Regeneration
A.04.a. Regeneration – CNS - A.05. Axon and Dendrite Development
A.05.a. Axon growth and guidance
A.05.b. Dendritic growth and branching - A.06. Synaptogenesis and Activity-Dependent Development
A.06.a. Synapse formation
A.06.b. Synapse maturation and remodeling
A.06.c. Neural circuit maturation and remodeling - A.07. Developmental Disorders
A.07.a. Autism – Behavioral analysis
A.07.b. Autism – Genetic models
A.07.c. Autism – Synaptic and cellular mechanisms
A.07.d. Autism – Physiology and systems
A.07.e. Rett syndrome
A.07.f. Fragile X
A.07.g. Down syndrome
A.07.h. Angelman and other developmental disorders
A.07.i. ADHD, SLI, dyslexia, and other specific disorders of neurobehavior
A.07.j. Animal models of autism
A.07.k. Animal models of developmental disorders other than autism
A.07.l. Molecular mechanisms - A.08. Development of Neural Systems
A.08.a. Motor systems
A.08.b. Sensory systems
A.08.c. Other systems - A.09. Adolescent Development
A.09.a. Animal models
A.09.b. Human imaging
A.09.c. Mechanisms of vulnerability - A.10. Development and Evolution
A.10.a. Comparative anatomy
A.10.b. Comparative cellular and molecular mechanisms
Theme B: Neural Excitability, Synapses, and Glia
- B.01. Transmitters, Transporters, and Other Signaling Molecules
B.01.a. Acetylcholine and glutamate
B.01.b. GABA and glycine
B.01.c. Catecholamines and purines
B.01.d. Neuropeptides, cytokines, growth factors, and other signaling molecules - B.02. Transmitter Receptors and Ligand-Gated Ion Channels
B.02.a. Ligand-gated receptors and ion channels – Glutamate
B.02.b. Ligand-gated receptors and ion channels – Acetylcholine
B.02.c. Ligand-gated receptors and ion channels – GABA and glycine
B.02.d. G-protein coupled receptors - B.03. Ion Channels
B.03.a. Voltage-gated sodium channels
B.03.b. Voltage-gated calcium channels
B.03.c. Voltage-gated potassium channels
B.03.d. Other ion channels - B.04. Synaptic Transmission
B.04.a. Presynaptic mechanisms, organization, and structure
B.04.b. Transsynaptic organization and structure
B.04.c. Postsynaptic organization and structure
B.04.d. Pre- and postsynaptic modulation - B.05. Synaptic Plasticity
B.05.a. LTP and LTD – Pre- and postsynaptic mechanisms
B.05.b. LTP and LTD – Kinases, phosphatases, and intracellular signaling
B.05.c. Short-term and spike-timing dependent plasticity
B.05.d. Homeostatic plasticity
B.05.e. Structural plasticity – Synapses
B.05.f. Structural plasticity – Neurons and networks
B.05.g. Transcription and translation in plasticity
B.05.h. Other - B.06. Intrinsic Membrane Properties and Signal integration
B.06.a. Intrinsic properties and modulation of neuronal firing
B.06.b. Somatic and dendritic integration - B.07. Network Interactions
B.07.a. Oscillations and synchrony – Unit studies
B.07.b. Oscillations and synchrony – EEG studies
B.07.c. Oscillations and synchrony – LFP studies
B.07.d. Network interactions – Other
B.07.e. Computational modelling of synaptic networks - B.08. Epilepsy
B.08.a. Channels and synaptic mechanisms
B.08.b. Networks and post-seizure modifications
B.08.c. In vivo and behavior
B.08.d. Animal models
B.08.e. Anticonvulsant and antiepileptic therapies
B.08.f. Human studies - B.09. Glial Mechanisms
B.09.a. Astrocytes – Biology
B.09.b. Astrocytes – Disease mechanisms
B.09.c. Microglia – Biology
B.09.d. Microglia – Disease mechanisms
B.09.e. Oligodendrocytes – Biology
B.09.f. Oligodendrocytes – Disease mechanisms
B.09.g. Glial cells in the PNS - B.10. Multiple Sclerosis and Other Demyelinating Diseases
B.10.a. Molecular and cellular mechanisms
B.10.b. Human and animal studies and therapeutics - B.11. Neuro-Oncology
B.11.a. Neuro-oncology
Theme C: Neurodegenerative Disorders and Injury
- C.01. Brain Wellness and Aging
C.01.a. Molecular and cellular changes
C.01.b. Metabolism, oxidative stress, and cellular mechanisms
C.01.c. Pharmacological and non-pharmacological interventions
C.01.d. Systemic factors and brain function
C.01.e. Brain wellness – Mechanisms and biomarkers - C.02. Alzheimer's Disease and Other Dementias
C.02.a. Alzheimer's disease – Genetics
C.02.b. Alzheimer's disease – Genomics and other omics approaches
C.02.c. Alzheimer's disease – Neuroinflammation and immune actions – In vitro models
C.02.d. Alzheimer's disease – Neuroinflammation and immune actions – In vivo models
C.02.e. Glial cells and Alzheimer’s disease
C.02.f. Vasculature, BBB, and AD
C.02.g. Mechanisms of synaptic dysfunction in Alzheimer's disease – In vitro models
C.02.h. Mechanisms of synaptic dysfunction in Alzheimer's disease – In vivo models
C.02.i. Neural circuits and AD
C.02.j. Clinical and pre-clinical imaging studies in Alzheimer's disease
C.02.k. Abeta mechanisms
C.02.l. APP/Abeta pathway – Cellular and animal models
C.02.m. Tau – In vitro models
C.02.n. Tau – In vivo models
C.02.o. ApoE and associated pathways
C.02.p. Altered energy homeostasis in Alzheimer's disease
C.02.q. Therapeutic strategies – In vitro models
C.02.r. Therapeutic strategies – Mouse models
C.02.s. Therapeutic strategies – Other animal models
C.02.t. Therapeutic strategies – Other
C.02.u. Other dementias, proteinopathies, and pathologies
C.02.v. Biomarkers - C.03. Parkinson’s Disease
C.03.a. Cellular mechanisms
C.03.b. LRRK2 and mitochondrial mechanisms, targets, and pathways
C.03.c. Dopamine and non-dopamine pathways
C.03.d. Alpha-synuclein – Models
C.03.e. Alpha-synuclein – Mechanisms and transmission
C.03.f. Circuit mechanisms
C.03.g. Parkinson's disease – Animal models
C.03.h. Neuroprotective mechanisms
C.03.i. Therapeutic strategies – Cellular models
C.03.j. Therapeutic strategies – Preclinical animal models – Small molecule therapeutics
C.03.k. Therapeutic strategies – Preclinical animal models – Other therapeutics
C.03.l. Therapeutic strategies – Clinical trials
C.03.m. Human studies – Genetics and diagnostic - C.04. Movement Disorders other than Parkinson's Disease
C.04.a. Huntington's disease – Molecular mechanisms
C.04.b. Huntington's disease – Preclinical and clinical trials
C.04.c. Ataxias and dystonia
C.04.d. Other diseases – Cellular and molecular mechanisms - C.05. Tauopathies, Synucleinopathies, and Other Related Diseases
C.05.a. Cellular and molecular mechanisms
C.05.b. Animal models - C.06. Neuromuscular Diseases
C.06.a. ALS and motor neuron diseases – Human genetics and cellular mechanisms
C.06.b. ALS and motor neuron diseases – In vitro studies
C.06.c. ALS and motor neuron diseases – Animal models
C.06.d. ALS and motor neuron diseases – Therapeutics
C.06.e. Other neuromuscular diseases
C.06.f. Peripheral nerve diseases and regeneration - C.07. Neurotoxicity, Inflammation, and Neuroprotection
C.07.a. Mechanisms of cellular stress and degeneration
C.07.b. Neuroprotective mechanisms – Preclinical – Small model therapeutics
C.07.c. Neuroprotective mechanisms – Preclinical – Other therapeutics
C.07.d. Neuroinflammation – Microglia
C.07.e. Neuroinflammation – Beyond microglia
C.07.f. Neuroinflammation – Neurodegeneration
C.07.g. Neuroinflammation – Animal models
C.07.h. Neuroinflammation – HIV and infections
C.07.i. Neuroinvasive viruses - C.08. Ischemia
C.08.a. Ischemia – Molecular and cellular mechanisms
C.08.b. Ischemia and hemorrhage – Animal models
C.08.c. Ischemia – Therapeutic, interventional, and translational studies - C.09. Stroke
C.09.a. Stroke, damage, or disease – Imaging and assessment
C.09.b. Stroke, damage, or disease – Mechanisms of abnormal movement
C.09.c. Stroke recovery – Pharmacological approaches to therapy
C.09.d. Stroke recovery – Non-pharmacological approaches to therapy - C.10. Brain Injury and Trauma
C.10.a. Brain injury – Cellular and molecular mechanisms
C.10.b. Brain injury – Animal models – Mechanisms
C.10.c. Brain injury – Animal models – Biomarkers and histology
C.10.d. Brain injury – Human studies
C.10.e. Brain injury – Therapeutic strategies
C.10.f. Peripheral nerve trauma, crush, and toxic injury - C.11. Spinal Cord Injury and Plasticity
C.11.a. Spinal cord injury – Cellular and molecular mechanisms
C.11.b. Spinal cord injury – Animal models and human studies
C.11.c. Spinal cord injury – Therapeutic strategies – In vivo – Pharmacological
C.11.d. Spinal cord injury – Therapeutic strategies – In vivo – Non-pharmacological
C.11.e. Spinal cord injury – Recovery
C.11.f. Spinal cord injury – Training, rehabilitation, and repair
C.11.g. Spinal cord injury – Plasticity and recovery
Theme D: Sensory Systems
- D.01. Somatosensation – Pain and Itch
D.01.a. Nociceptors and pruitoceptors
D.01.b. Headache, migraine, and trigeminal circuits
D.01.c. Spinal and subcortical circuits
D.01.d. Cortical processing
D.01.e. Descending modulation
D.01.f. Pain models
D.01.g. Inflammatory pain
D.01.h. Peripheral mechanisms of neuropathic pain
D.01.i. Central mechanisms of neuropathic pain
D.01.j. Pain imaging and perception
D.01.k. Opioids
D.01.l. Non-opioid treatments for persistent pain
D.01.m. Itch - D.02. Somatosensation – Touch
D.02.a. Peripheral mechanisms
D.02.b. Spinal circuits
D.02.c. Plasticity and reorganization
D.02.d. Thalamic and cortical processing
D.02.e. Barrel cortex
D.02.f. Stimulus feature receptive fields and response properties
D.02.g. Stimulus feature neural coding - D.03. The Chemical Senses
D.03.a. Olfaction – Peripheral mechanisms
D.03.b. Olfaction – Higher-order circuits
D.03.c. Olfaction – Behavior, perception, and its relation to neurophysiology
D.03.d. Taste - D.04. Interoception
D.04.a. Peripheral mechanisms – Mechanosensation
D.04.b. Peripheral mechanisms – Proprioception
D.04.c. Peripheral mechanisms – Chemosensation
D.04.d. Peripheral mechanisms – Vagal afferents
D.04.e. Central pathways - D.05. Auditory and Vestibular Systems
D.05.a. Hair cells and the periphery
D.05.b. Auditory processing – Sound localization and binaural interactions
D.05.c. Auditory processing – Temporal, frequency, and spectral processing
D.05.d. Auditory processing – Vocalizations and natural sounds
D.05.e. Auditory processing – Circuits, synapses, and neurotransmitters
D.05.f. Auditory processing – Adaptation, learning, and memory
D.05.g. Auditory processing – Neural coding, experiment, and theory
D.05.h. Auditory processing – Perception, cognition, and action
D.05.i. Vestibular processing and perception - D.06. Vision
D.06.a. Photoreceptors
D.06.b. Retinal circuitry
D.06.c. Visual pathways – Subcortical and other
D.06.d. Visual cortex – Circuits
D.06.e. Visual cortex – Populations
D.06.f. Visual system – Responses during behavior
D.06.g. Visual system – Response modulation and adaptation
D.06.h. Higher visual areas
D.06.i. Visual cortex – Functional architecture and circuits
D.06.j. Visual system – Plasticity
D.06.k. Processing of contrast, form, and color
D.06.l. Visual motion
D.06.m. Representation of objects and scenes
D.06.n. Representation of faces and bodies
D.06.o. Visual learning, memory, and categorization
D.06.p. Spatial and feature-based attention
D.06.q. Visual cognition – Decision making - D.07. Visual Sensory-Motor Processing
D.07.a. Sensorimotor transformation – Behavior and whole animal
D.07.b. Sensorimotor transformation – Neuroprocessing - D.08. Multisensory Integration
D.08.a. Cross-modal processing – Spatial and temporal factors
D.08.b. Cross-modal processing – Neural circuitry and development
D.08.c. Cross-modal processing – In humans
Theme E: Motor Systems
- E.01. Eye Movements
E.01.a. Eye movements – Central mechanisms, perception, and cognition
E.01.b. Eye movements – Saccades - E.02. Cerebellum
E.02.a. Cerebellum – Cell types and circuit physiology
E.02.b. Cerebellum – Sensorimotor
E.02.c. Cerebellum – Climbing fibers and learning
E.02.d. Cerebellum – Interactions with other brain areas
E.02.e. Cerebellum – Non-motor functions
E.02.f. Cerebellum – Human studies - E.03. Basal Ganglia
E.03.a. Transmitters and neuromodulation
E.03.b. Physiology and plasticity
E.03.c. Systems behavior - E.04. Voluntary Movements
E.04.a. Finger and grasp control – Normal human behavior
E.04.b. Reaching control – Action and sensation
E.04.c. Reaching control – Movement selection and strategy
E.04.d. Reaching control – Motor learning – Human psychophysics
E.04.e. Reaching control – Motor learning – Human neurophysiology
E.04.f. Reaching control – Motor learning – Animal
E.04.g. Interlimb and bimanual control
E.04.h. Cortical planning and execution – Behavior
E.04.i. Cortical planning and execution – Neurophysiology – Human
E.04.j. Cortical planning and execution – Neurophysiology
E.04.k. Cortical planning and execution – Neuroimaging
E.04.l. Motor planning and execution – Behavior and neurophysiology
E.04.m. Oral motor and speech - E.05. Brain-Machine Interface
E.05.a. Neurophysiology – Non-invasive techniques
E.05.b. Neurophysiology – Implanted electrodes and other direct interactions with neurons
E.05.c. Neurophysiology – Decoding and neural processing
E.05.d. Neuroprosthetics – Control of real and artificial arm, hand, other grasping devices
E.05.e. Neuroprosthetics – Other motor sensory interfaces (e.g. artificial vision) - E.06. Posture and Gait
E.06.a. Posture and gait – Kinematics, muscle activity, exercise and fatigue, and biomechanics
E.06.b. Posture and gait – Afferent control
E.06.c. Posture and gait – Higher order control, multi-task integration, and theory
E.06.d. Posture and gait – Aging, injury, and disease
E.06.e. Reflexes and reflex modulation - E.07. Rhythmic Motor Pattern Generation
E.07.a. Cellular properties – Interneurons and motor neurons
E.07.b. Connectivity
E.07.c. Neuromodulation of neuronal and synaptic properties
E.07.d. Afferent and descending control - E.08. Respiratory Regulation
E.08.a. Respiratory control - E.09. Motor Neurons and Muscle
E.09.a. Motor neurons – Activity, sensory, and central control – Exercise, injury, and disease
E.09.b. Motor neurons – Development, identification, intrinsic properties, and modulation
E.09.c. Motor unit recordings, kinematics, and EMG
E.09.d. Motorneuron-muscle interface and muscle physiology/biochemistry
Theme F: Integrative Physiology and Behavior
- F.01. Neuroethology
F.01.a. Sensory systems
F.01.b. Sensory motor systems
F.01.c. Vocal/social communication – Anatomy, cellular, and genetic
F.01.d. Vocal/social communication – Physiology and behavior - F.02. Neuroendrocrine Processes and Behavior
F.02.a. Social, sexual, and parental behaviors
F.02.b. Defensive behavior and aggression
F.02.c. Hormones and cognition
F.02.d. Neuroendocrine anatomy and physiology - F.03. Stress and the Brain
F.03.a. Stress and neuroimmunology
F.03.b. Cellular actions of stress
F.03.c. Early-life Stress – Neural, neurochemical, and physiologic effects
F.03.d. Early-life Stress – Molecular mechanisms and cellular effects
F.03.e. Early-life Stress – Effects on anxiety, social function, and depression
F.03.f. Early-life Stress – Adolescence
F.03.g. Stress-modulated pathways – Cognition, learning, and memory circuits
F.03.h. Stress-modulated pathways – Reward and motivational drive circuits
F.03.i. Stress and cognition – Molecular, cellular, genetic
F.03.j. Stress-modulated pathways – Anatomy, physiology, neurochemistry - F.04. Neuroimmunology and Neurovirology
F.04.a. Regulating systems
F.04.b. Behavioral effects
F.04.c. Neurovirology - F.05. Brain Blood Flow, Metabolism, and Homeostasis
F.05.a. Energy metabolism
F.05.b. Blood flow
F.05.c. Blood brain barrier
F.05.d. Functional imaging - F.06. Autonomic Regulation
F.06.a. Cardiovascular regulation
F.06.b. Gastrointestinal, renal, urinary, and reproductive regulation
F.06.c. Thermoregulation and other - F.07. Biological Rhythms and Sleep
F.07.a. Entrainment and phase shifts
F.07.b. Molecular biology and physiology of clocks
F.07.c. Sleep regulation – Molecular, cellular, and pharmacological
F.07.d. Sleep regulation – Anatomy, physiology, neurochemistry
F.07.e. Sleep – Systems
F.07.f. Sleep – Behavior - F.08. Food and Water Intake and Energy Balance
F.08.a. Integration of peripheral signals
F.08.b. Central pathways – Anatomy and development
F.08.c. Neuropeptide regulators
F.08.d. Monoamines, amino acids, and other regulators
Theme G: Motivation and Emotion
- G.01. Fear and Aversive Learning and Memory
G.01.a. Acquisition and memory modification
G.01.b. Neural circuits
G.01.c. Neural mechanisms - G.02. Reward and Appetitive Learning and Memory
G.02.a. Acquisition and memory modification
G.02.b. Neural circuits
G.02.c. Neural mechanisms
G.02.d. Neuropharmacology - G.03. Motivation
G.03.a. Motivation – Regulation of aversive behavior
G.03.b. Motivation – Regulation of reward-related behavior
G.03.c. Motivation – Higher cognitive processing
G.03.d. Motivation – Social communication and behavior - G.04. Emotion
G.04.a. Human emotion
G.04.b. Emotion – Neural circuitry
G.04.c. Emotion – Fear, anxiety, and pain
G.04.d. Emotion – Positive and negative emotional states - G.05. Mood Disorders
G.05.a. Human imaging and behavioral studies
G.05.b. Treatment and drug discovery
G.05.c. Animal models – Behavioral paradigms and processes
G.05.d. Animal models – Neural mechanisms
G.05.e. Animal models of therapeutics - G.06. Anxiety Disorders
G.06.a. Human studies and therapeutic approaches
G.06.b. Preclinical models - G.07. Post-Traumatic Stress Disorder
G.07.a. Human studies and therapeutic approaches
G.07.b. Preclinical models - G.08. Other Psychiatric Disorders
G.08.a. Preclinical models, human studies, and therapeutic approaches - G.09. Drugs of Abuse and Addiction
G.09.a. Addictive drugs – Developmental effects
G.09.b. Addictive drugs – Drug tolerance, dependence, and toxicity
G.09.c. Addictive drugs - Neural mechanism
G.09.d. Addiction – Genetics, translational, and clinical studies
G.09.e. Addiction – Learning and memory
G.09.f. Alcohol – Neural circuits and neurophysiology
G.09.g. Alcohol – Cognitive and behavioral effects
G.09.h. Alcohol – Molecular mechanisms
G.09.i. Drug discovery and treatment
G.09.j. Amphetamines – Mechanisms of addiction
G.09.k. Cannabinoids – Behavioral and neural mechanisms and addiction
G.09.l. Cocaine – Reinforcement, seeking, reinstatement, and other behavioral effects
G.09.m. Cocaine – Cell signaling, circuitry, and neurophysiology
G.09.n. Opioids – Reinforcement, seeking, and reinstatement
G.09.o. Opioids – Cell signaling, circuitry, and neurophysiology
G.09.q. Nicotine – Behavioral and cognitive effects
G.09.r. Nicotine – Physiological effects
G.09.s. Hallucinogens – Neural mechanisms
Theme H: Cognition
- H.01. Attention
H.01.a. Attentional networks
H.01.b. Mechanisms of attention – Human studies
H.01.c. Mechanisms of attention – Animal models - H.02. Perception and Imagery
H.02.a. Human perception, imagery, and imagination - H.03. Decision Making
H.03.a. Computational models
H.03.b. Prefrontal cortex
H.03.c. Orbitofrontal cortex
H.03.d. Corticolimbic circuits
H.03.e. Neural mechanisms – Choice
H.03.f. Neural mechanisms – Value
H.03.g. Neural mechanisms - Risk and ambiguity - H.04. Executive Functions
H.04.a. Prefrontal mechanisms
H.04.b. Network activity
H.04.c. Effects on learning and memory
H.04.d. Inhibitory control
H.04.e. Disorders of executive functions and inhibitory control - H.05. Working Memory
H.05.a. Central and prefrontal mechanisms
H.05.b. Distributed mechanisms
H.05.c. Behavioral studies - H.06. Social Cognition
H.06.a. Human behavior, disorders, and mechanisms
H.06.b. Animal behavior
H.06.c. Circuits and neural mechanisms - H.07. Long-Term Memory
H.07.a. Consolidation and reconsolidation – Behavior
H.07.b. Consolidation and reconsolidation – Molecular mechanisms
H.07.c. Consolidation and reconsolidation – Neural circuit mechanisms
H.07.d. Human LTM – Medial temporal lobe
H.07.e. Human LTM – Encoding and retrieval
H.07.f. Episodic and episodic-like memory - H.08. Learning and Memory
H.08.a. Prefrontal cortex networks
H.08.b. Other cortical networks
H.08.c. Subcortical circuits
H.08.d. Striatal and corticostriatal circuits
H.08.e. Hippocampal – Formation circuitry
H.08.f. Hippocampal – Cortical interactions
H.08.g. Hippocampal – Subcortical interactions
H.08.h. Intrinsic hippocampal circuits
H.08.i. Dentate gyrus
H.08.j. The role of oscillations
H.08.k. Genes and molecular mechanisms
H.08.l. Physiology
H.08.m. Pharmacology
H.08.n. Invertebrates
H.08.o. Timing and temporal processing - H.09. Spatial Navigation
H.09.a. Intrinsic hippocampal circuits
H.09.b. Cortical circuits
H.09.c. Cortico-hippocampal interactions
H.09.d. Place cells
H.09.e. Grid cells and other spatially modulated cells
H.09.f. Human navigation
H.09.g. Animal navigation - H.10. Human Learning and Cognition
H.10.a. Relational and spatial learning
H.10.b. Motor and skill learning
H.10.c. Feedback, reinforcement, and reward
H.10.d. Associative learning
H.10.e. Timing and temporal processing - H.11. Language
H.11.a. Language – Acquisition and usage
H.11.b. Disorders
H.11.c. Neural circuits and mechanisms - H.12. Aging and Development
H.12.a. Natural brain aging – Behavior and cognitive disorders
H.12.b. Natural brain aging – Neural mechanisms
H.12.c. Learning and memory in aging - H.13. Schizophrenia
H.13.a. Neuropathology, genetics, genomics, and molecular mechanisms
H.13.b. Behavior and symptoms
H.13.c. Circuits and systems
H.13.d. Animal models – Developmental
H.13.e. Schizophrenia therapeutics – Animal and human studies
Theme I: Techniques
- I.01. Molecular, Biochemical, and Genetic Techniques
I.01.a. Biochemical and molecular techniques
I.01.b. Genetic techniques
I.01.c. Genomic and transcriptomic techniques
I.01.d. Single-cell techniques - I.02. Systems Biology and Bioinformatics
I.02.a. Genomics, proteomics, and bioinformatics
I.02.b. Systems biology and multiomics approaches - I.03. Anatomical Methods
I.03.a. Sample preparation and novel probes
I.03.b. Light and electron microscopy
I.03.c. Circuit tracing
I.03.d. Connectomics - I.04. Physiological Methods
I.04.a. Optical methodology – Development
I.04.b. Optical methodology – Application
I.04.c. Probe design and engineering
I.04.d. Electrophysiology – Cellular
I.04.e. Electrophysiology – Neural networks
I.04.f. Electrophysiology – Electrode arrays - I.05. Biomarker, Drug Discovery, and Experimental Therapeutics
I.05.a. Affective disorders and schizophrenia
I.05.b. Neurodegenerative diseases (AD, PD, MS, stroke)
I.05.c. Drug delivery
I.05.d. Gene, protein, or cell based approaches - I.06. Computation, Modeling, and Simulation
I.06.a. Cellular models
I.06.b. Network models
I.06.c. Network computations – Theory and modeling
I.06.d. Network computations – Data analytics and statistics
I.06.e. Computational tools – Experimental
I.06.f. Computational tools – Analytical - I.07. Data Analysis and Statistics
I.07.a. Data analysis and statistics – Human data
I.07.b. Software Tools - I.08. Methods to Modulate Neural Activity
I.08.a. Electrical
I.08.b. Optogenetic
I.08.c. Other
Theme J: History, Education, and Society
- J.01. History of Neuroscience
J.01.a. History of neuroscience - J.02. Teaching of Neuroscience
J.02.a. K-12 teaching and outreach
J.02.b. College
J.02.c. Graduate and professional - J.03. Public Awareness of Neuroscience
J.03.a. Outreach activities - J.04. Ethical and Policy Issues in Neuroscience
J.04.a. Ethical and policy issues in neuroscience
